Surinder S. Birring
Kappa and Mu Opioid Receptors in Chronic Cough: Current Evidence and Future Treatment
Birring, Surinder S.; Dicpinigaitis, Peter V.; Maher, Toby M.; Mazzone, Stuart B.; Page, Clive P.; Hawi, Amale; Sciascia, Thomas; Morice, Alyn H.
Authors
Peter V. Dicpinigaitis
Toby M. Maher
Stuart B. Mazzone
Clive P. Page
Amale Hawi
Thomas Sciascia
Professor Alyn Morice A.H.Morice@hull.ac.uk
Foundation Chair and Professor of Respiratory Medicine
Abstract
Chronic cough is a significant burden on patient quality of life and is associated with poor health outcomes. Chronic cough may be a result of neural hypersensitivity due to changes in both the peripheral and the central nervous systems, although the exact mechanisms underlying its pathogenesis are not completely understood. Opioid receptors, specifically kappa and mu, are potential therapeutic targets in the management of chronic cough because they play a pivotal role in both the peripheral and the central neural pathways implicated in the act of coughing. Morphine, a mu opioid receptor agonist, is an effective cough modulator; however, mu receptor agonists are part of a drug class that can induce respiratory depression and euphoria, with strong reinforcing properties that may lead to excessive use and abuse. Drugs with a dual-acting mechanism of kappa receptor agonism and mu receptor antagonism may be effective in the management of chronic cough without the potential for abuse. This review summarizes the current understanding of the mechanisms of cough hypersensitivity, the role of the kappa and mu receptors in the neurophysiology of cough, and the clinical potential of targeting these receptors as a novel way of managing chronic cough.
Citation
Birring, S. S., Dicpinigaitis, P. V., Maher, T. M., Mazzone, S. B., Page, C. P., Hawi, A., Sciascia, T., & Morice, A. H. (2025). Kappa and Mu Opioid Receptors in Chronic Cough: Current Evidence and Future Treatment. Lung, 203, Article 62. https://doi.org/10.1007/s00408-025-00812-8
Journal Article Type | Review |
---|---|
Acceptance Date | Apr 14, 2025 |
Online Publication Date | May 13, 2025 |
Publication Date | 2025 |
Deposit Date | May 27, 2025 |
Publicly Available Date | May 28, 2025 |
Print ISSN | 0341-2040 |
Publisher | Springer Verlag |
Peer Reviewed | Peer Reviewed |
Volume | 203 |
Article Number | 62 |
DOI | https://doi.org/10.1007/s00408-025-00812-8 |
Public URL | https://hull-repository.worktribe.com/output/5182970 |
Files
Published article
(643 Kb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0
Copyright Statement
© The Author(s) 2025
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long
as you give appropriate credit to the original author(s) and the source,
provide a link to the Creative Commons licence, and indicate if changes
were made. The images or other third party material in this article are
included in the article's Creative Commons licence, unless indicated
otherwise in a credit line to the material.
You might also like
British Thoracic Society Clinical Statement on chronic cough in adults
(2023)
Journal Article
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search